Does IFIH1 (MDA5) activate type I interferon signaling and does the rs1990760 TT genotype increase interferon activity and autoimmune risk?

The cytosolic sensor MDA5 (encoded by the IFIH1 gene) is a vital component of the innate immune system, recognizing viral double-stranded RNA (dsRNA) to initiate protective interferon responses.

Mechanistic activation and signaling

• dsRNA Sensing: MDA5 acts as a pattern recognition receptor, cooperatively binding long cytosolic viral dsRNA and assembling into ATP-dependent helical filaments to distinguish viral from self-RNA.
• Downstream Cascade: This assembly exposes N-terminal CARD domains, prompting homotypic CARD-CARD interactions that aggregate the mitochondrial adaptor protein MAVS.
• Interferon Induction: Aggregated MAVS recruits and activates the kinases TBK1 and IKKε, which phosphorylate transcription factors IRF3 and IRF7. Phosphorylated IRF3 dimerizes and translocates to the nucleus to assemble the interferon-β (IFN-β) enhanceosome, driving robust type I interferon transcription.

Genetic variation and autoimmune risk

• Gain-of-Function Variant: The rs1990760 polymorphism is a missense mutation (Ala946Thr). The T allele serves as a gain-of-function driver, yielding a hyper-responsive MDA5 state with elevated basal and induced type I interferon-stimulated gene (ISG) expression.
• Autoimmune Susceptibility: The homozygous TT genotype increases sensitivity to interferon-alpha and is associated with a heightened risk of systemic lupus erythematosus (SLE), type 1 diabetes (T1D), rheumatoid arthritis, and multiple sclerosis.
• Risk Metrics: Epidemiological data demonstrate a per-allele odds ratio (OR) of approximately 1.1 to 1.2, rising to an OR of 1.2 to 1.4 for TT homozygotes. Conversely, loss-of-function IFIH1 variants that dampen interferon signaling are protective against T1D.

Bottom line

• The claim is fully supported: IFIH1 (MDA5) initiates a MAVS-TBK1-IRF3 signaling cascade upon sensing viral dsRNA, and the rs1990760 TT genotype acts as a functional genetic variant that drives interferon hyper-responsiveness and increases polygenic autoimmune disease susceptibility.